WHO welcomes report on efficacy of longer gaps between AstraZeneca doses

WHO welcomes report on efficacy of longer gaps between AstraZeneca doses
Reuters
Share
Font Size
Save
Comment
Synopsis

Joachim Hombach, head of the WHO's expert panel, said it was "great news" on spaced dosing for the vaccine, which would add flexibility to dosing schedules.

Agencies
Representative Image
A report from Oxford University saying that a longer gap between doses of vaccines still provides protection is "very reassuring" for supply-strapped countries, World Health Organization chief scientist Soumya Swaminathan said on Friday.

Joachim Hombach, head of the WHO's expert panel, said it was "great news" on spaced dosing for the vaccine, which would add flexibility to dosing schedules.

The Oxford study released this week found that the second dose can be delayed up to 45 weeks and still lead to an enhanced immune response.

Did you Know?

Stock score of Astrazeneca Pharma India Ltd moved down by 1 in 6 months on a 10-point scale.

View Latest Stock Report »

Read More News on

(Catch all the Business News, Breaking News Events and Latest News Updates on The Economic Times.)

Download The Economic Times News App to get Daily Market Updates & Live Business News.

ETPrime stories of the day